相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses
Isabelle K. Vila et al.
CELL METABOLISM (2022)
STING controls nociception via type I interferon signalling in sensory neurons
Christopher R. Donnelly et al.
NATURE (2021)
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway
Laura Cheradame et al.
ONCOGENE (2021)
Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes
Clara Taffoni et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
Marwa Elsayed et al.
BIOMEDICINES (2021)
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
Amanda Rosewell Shaw et al.
COMMUNICATIONS BIOLOGY (2021)
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton et al.
CANCER CELL (2021)
Drosophila STING protein has a role in lipid metabolism
Katarina Akhmetova et al.
ELIFE (2021)
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege
Casey R. Ager et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar et al.
CANCERS (2021)
CD8+ T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal-9 pathway
Jinglian Tao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Erin Helms et al.
Cancer Discovery (2020)
Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
Carole Siret et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lysyl-tRNA synthetase produces diadenosine tetraphosphate to curb STING-dependent inflammation
J. Guerra et al.
SCIENCE ADVANCES (2020)
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
Esther N. Arwert et al.
NATURE CELL BIOLOGY (2020)
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel N. Hosein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists
Christopher J. Nicolai et al.
SCIENCE IMMUNOLOGY (2020)
Unique Spatial Immune Profiling in Pancreatic Ductal Adenocarcinoma with Enrichment of Exhausted and Senescent T Cells and Diffused CD47-SIRP∝ Expression
Alexandros Papalampros et al.
CANCERS (2020)
Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis via Reversing Epithelial-Mesenchymal Transition
Hao Cheng et al.
FRONTIERS IN ONCOLOGY (2020)
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
Saber Amin et al.
RADIATION ONCOLOGY (2020)
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Xueguang Lu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Leila Motedayen Aval et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives
Laurenz Nagl et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Development of small molecule inhibitors/agonists targeting STING for disease
Kaifeng Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype
Francesca Marcon et al.
ONCOIMMUNOLOGY (2020)
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
Claudia Minici et al.
ONCOIMMUNOLOGY (2020)
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Roman M. Chabanon et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
Kim Vriens et al.
NATURE (2019)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression
Atsunori Kamiya et al.
NATURE NEUROSCIENCE (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Hannah Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo
Xin Xie et al.
CARBOHYDRATE POLYMERS (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
David G. Leach et al.
BIOMATERIALS (2018)
Dynamic Structural Differences between Human and Mouse STING Lead to Differing Sensitivity to DMXAA
Amy Y. Shih et al.
BIOPHYSICAL JOURNAL (2018)
CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B. Candido et al.
CELL REPORTS (2018)
B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses
Melissa M. Walker et al.
JOURNAL OF IMMUNOLOGY (2018)
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer
Heather L. Kinkead et al.
JCI INSIGHT (2018)
Myeloid-derived suppressor cells and their role in pancreatic cancer
M. Pergamo et al.
CANCER GENE THERAPY (2017)
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
Abul Azad et al.
EMBO MOLECULAR MEDICINE (2017)
The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele
Seema Patel et al.
JOURNAL OF IMMUNOLOGY (2017)
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Silvia Cerboni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway
Juli Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang et al.
NATURE COMMUNICATIONS (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
Jonas R. M. Van Audenaerde et al.
ONCOTARGET (2017)
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and CanBe Targeted to Enhance Anti-tumor Response
Vijay K. Gonugunta et al.
CELL REPORTS (2017)
Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
Jung-Eun Jang et al.
CELL REPORTS (2017)
Type I Interferons and Natural Killer Cell Regulation in Cancer
Lena Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression
Richard L. Bakst et al.
CANCER RESEARCH (2017)
Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
Jason R. Baird et al.
CANCER RESEARCH (2016)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Giovanni Francesco Castino et al.
ONCOIMMUNOLOGY (2016)
Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
Chih-Hang Anthony Tang et al.
CANCER RESEARCH (2016)
Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection
Martin K. Thomsen et al.
HEPATOLOGY (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
Joao Incio et al.
CANCER DISCOVERY (2016)
Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
Tianli Xia et al.
CELL REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
T Lymphocyte-Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
Christopher V. Carman et al.
FRONTIERS IN IMMUNOLOGY (2015)
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Lingyin Li et al.
NATURE CHEMICAL BIOLOGY (2014)
An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
Yichen Tang et al.
PLOS ONE (2014)
Inflammation-driven carcinogenesis is mediated through STING
Jeonghyun Ahn et al.
NATURE COMMUNICATIONS (2014)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y. Ino et al.
BRITISH JOURNAL OF CANCER (2013)
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions
Amedeo Amedei et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Endoneurial Macrophages Induce Perineural Invasion of Pancreatic Cancer Cells by Secretion of GDNF and Activation of RET Tyrosine Kinase Receptor
Oren Cavel et al.
CANCER RESEARCH (2012)
DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular
Christina M. Buchanan et al.
CLINICAL SCIENCE (2012)
Lipid metabolism in cancer
Claudio R. Santos et al.
FEBS JOURNAL (2012)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
Type I IFN contributes to NK cell homeostasis, activation, and antitumor function
Jeremy B. Swann et al.
JOURNAL OF IMMUNOLOGY (2007)
Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
LM Ching et al.
BRITISH JOURNAL OF CANCER (2002)
IFN-α/β enhances BCR-dependent B cell responses
D Braun et al.
INTERNATIONAL IMMUNOLOGY (2002)